William McKee
Direktor/Vorstandsmitglied bei ASSERTIO HOLDINGS, INC.
Vermögen: 187 442 $ am 30.04.2024
Profil
Mr. William T.
McKee, CPA, is an Independent Director at Assertio Holdings, Inc. and a Chief Executive Officer at MBJC Associates LLC.
He is on the Board of Directors at Assertio Holdings, Inc., Viridos, Inc., Cerulean, Inc., NextRNA Therapeutics, Inc. and Windgap Medical, Inc. Mr. McKee was previously employed as a Treasurer, Chief Financial & Accounting Officer by C4 Therapeutics, Inc., an Independent Director by Aileron Therapeutics, Inc., an Independent Director by Assertio Therapeutics, Inc., an Independent Director by Agile Therapeutics, Inc., a Chief Operating & Financial Officer by EKR Therapeutics, Inc., an Independent Director by Auxilium Pharmaceuticals LLC, a Chief Financial Officer, Treasurer & EVP by Barr Pharmaceuticals, Inc., a VP-Finance & Director-International Operations by Absolute Entertainment, Inc., and a Senior Manager by Gramkow & Carnevale CPAs.
He also served on the board at AI Proteins, Inc., Cerulean Pharma, Inc., MedRhythms, Inc. and Vinci Pharmaceuticals, Inc. He received his undergraduate degree from the University of Notre Dame.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ASSERTIO HOLDINGS, INC.
0,25% | 12.04.2024 | 238 780 ( 0,25% ) | 187 442 $ | 30.04.2024 |
Aktive Positionen von William McKee
| Unternehmen | Position | Beginn |
|---|---|---|
| ASSERTIO HOLDINGS, INC. | Direktor/Vorstandsmitglied | 01.03.2017 |
| Cerulean, Inc. | Direktor/Vorstandsmitglied | - |
Windgap Medical, Inc.
 Windgap Medical, Inc. Pharmaceuticals: MajorHealth Technology Windgap Medical, Inc. engages in the development of epinephrine autoinjector for the treatment of anaphylaxis. The company was founded was founded by Christopher J. Stepanian and Brent Buchine and is headquartered in Somerville, MA. | Direktor/Vorstandsmitglied | - |
NextRNA Therapeutics, Inc.
 NextRNA Therapeutics, Inc. BiotechnologyHealth Technology NextRNA Therapeutics, Inc. is a biotechnology company that specializes in drug development services. The company is based in Cambridge, MA. The company was founded in 2021 by Leon Wert-Lamas, Marc A. Cohen, Julia Novina, Carl Novina, Dominique Verhelle, Kenneth C. Anderson, Robert S. Langer. Dominique Verhelle has been the CEO since 2021. | Direktor/Vorstandsmitglied | - |
Viridos, Inc.
 Viridos, Inc. Miscellaneous Commercial ServicesCommercial Services Viridos, Inc. develops and commercializes genomic-driven solutions and products. The firm's offerings are designed for application in solutions such as human health, food, water production, and environment. The company was founded by J. Craig Venter, Hamilton O. Smith, David C. Kiernan and Juan Enriquez-Cabot in February 2005 and is headquartered in La Jolla, CA. | Direktor/Vorstandsmitglied | 09.11.2016 |
| MBJC Associates LLC | Vorstandsvorsitzender | 01.02.2010 |
Ehemalige bekannte Positionen von William McKee
| Unternehmen | Position | Ende |
|---|---|---|
| AILERON THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 31.10.2023 |
| C4 THERAPEUTICS, INC. | Finanzdirektor/CFO | 21.06.2021 |
| AGILE THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 09.06.2020 |
| ░░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von William McKee
| University of Notre Dame | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| AGILE THERAPEUTICS, INC. | Health Technology |
| AILERON THERAPEUTICS, INC. | Health Technology |
| C4 THERAPEUTICS, INC. | Health Technology |
| ASSERTIO HOLDINGS, INC. | Health Technology |
| Private Unternehmen | 15 |
|---|---|
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
Barr Pharmaceuticals, Inc.
 Barr Pharmaceuticals, Inc. Pharmaceuticals: GenericHealth Technology Barr Pharmaceuticals, Inc. manufactures and sells generic prescription pharmaceutical products. The company was founded in 1970 and is headquartered in Montvale, NJ. | Health Technology |
Auxilium Pharmaceuticals LLC
 Auxilium Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Auxilium Pharmaceuticals LLC develops and markets pharmaceutical products. It specializes in men's healthcare area and has product portfolio and pipeline in orthopedics, dermatology and other therapeutic areas. The firm products include edex, Osbon, ErecAid, STENDRA, TESTOPEL, XIAFLEX and Testim. The company was founded by Gerri A. Henwood and Jane Holmes Hollingsworth in 1999 and is headquartered in Chesterbrook, PA. | Health Technology |
Viridos, Inc.
Viridos, Inc. Miscellaneous Commercial ServicesCommercial Services Viridos, Inc. develops and commercializes genomic-driven solutions and products. The firm's offerings are designed for application in solutions such as human health, food, water production, and environment. The company was founded by J. Craig Venter, Hamilton O. Smith, David C. Kiernan and Juan Enriquez-Cabot in February 2005 and is headquartered in La Jolla, CA. | Commercial Services |
EKR Therapeutics, Inc.
 EKR Therapeutics, Inc. Hospital/Nursing ManagementHealth Services EKR Therapeutics, Inc. is a specialty pharmaceutical company focused on acquiring, developing and maximizing the potential utility of critical-care hospital products offering broader therapeutic options and greater control to improve in-patient care, speed recovery, and achieve optimal outcomes. Backed by the strength of its award winning management team, the dedication of its field force of product specialists and its commitment to excellence in customer service and medical education, EKR has been organized to be a class leader in commercializing products to address unmet and under-satisfied medical needs or to otherwise enhance the therapeutic value of acute-care products. | Health Services |
Windgap Medical, Inc.
Windgap Medical, Inc. Pharmaceuticals: MajorHealth Technology Windgap Medical, Inc. engages in the development of epinephrine autoinjector for the treatment of anaphylaxis. The company was founded was founded by Christopher J. Stepanian and Brent Buchine and is headquartered in Somerville, MA. | Health Technology |
Absolute Entertainment, Inc.
 Absolute Entertainment, Inc. Miscellaneous Commercial ServicesCommercial Services Absolute Entertainment, Inc. provides DJ services for weddings and events. The private company is based in Hanover, MD. The company's top tier services cover various locations and events. | Commercial Services |
Cerulean Pharma, Inc.
 Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cerulean Pharma, Inc. is a clinical-stage, oncology-focused company, which provides proprietary Dynamic Tumor Targeting Platform to develop differentiated therapies. It specializes in the design and development of nanopharmaceuticals. Cerulean's nanopharmaceuticals are drug-containing nanoparticles designed and optimized to enhance therapeutic agents, ranging from small molecules to therapeutic peptides and RNAi molecules. The company was founded by Alan L. Crane and Ram Sasisekharn on November 28, 2005 and is headquartered in Waltham, MA. | Health Technology |
| Gramkow & Carnevale CPAs | |
| MBJC Associates LLC | |
MedRhythms, Inc.
 MedRhythms, Inc. Medical/Nursing ServicesHealth Services MedRhythms, Inc. is a digital therapeutics company based in Portland, ME. The company uses sensors, music, and software to develop evidence-based neurologic interventions to measure and improve walking. MedRhythms is dedicated to developing direct-stimulation digital therapeutics that provide direct stimulation to enable the mechanism of action in each relevant population. The company has an active pipeline of prescription digital therapeutics targeting rehabilitation and prevention in areas of neurologic injury and disease. The company's platform combines sensors, software, and music with advanced neuroscience to target neural circuitry. MedRhythms is on a mission to help people living with neurologic injuries and diseases optimize their health and independence through next-generation therapeutics to improve brain health. MedRhythms was founded in 2013 by Brian Harris and Owen McCarth, with Brian Harris serving as the CEO since then. | Health Services |
Vinci Pharmaceuticals, Inc.
 Vinci Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Vinci Pharmaceuticals, Inc. provides health care services. The company is headquartered in Avon-by-the-Sea, NJ. | Health Services |
NextRNA Therapeutics, Inc.
NextRNA Therapeutics, Inc. BiotechnologyHealth Technology NextRNA Therapeutics, Inc. is a biotechnology company that specializes in drug development services. The company is based in Cambridge, MA. The company was founded in 2021 by Leon Wert-Lamas, Marc A. Cohen, Julia Novina, Carl Novina, Dominique Verhelle, Kenneth C. Anderson, Robert S. Langer. Dominique Verhelle has been the CEO since 2021. | Health Technology |
AI Proteins, Inc.
 AI Proteins, Inc. Pharmaceuticals: MajorHealth Technology AI Proteins, Inc. is a biotech company based in Andover, MA. AI Proteins is focused on re-imagining protein therapeutics by designing entirely new proteins using an AI-based approach and a high-throughput drug discovery platform. The company's platform enables the development of inexpensive, durable, and highly specific proteins optimized for specific therapeutic applications. These proteins have the potential for oral delivery and can dramatically accelerate the development of lead therapeutic candidates ready for IND-enabling studies. The company was founded by Marc A. Cohen and Christopher Bahl. Noah D. Beerman has been the CEO of the company since 2023. | Health Technology |
| Cerulean, Inc. |
